{"meta":{"query_hash":"637f95c8f82d","filters":{"venue":"Neuropsychopharmacology Reports"},"cohort_total":17,"direct_labels_cover":0,"predictions_cover":17,"exported":17,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/637f95c8f82d","api":"https://metacan.xera.ac/api/v1/cohort?venue=Neuropsychopharmacology+Reports"},"results":[{"id":"W2886643569","doi":"10.1002/npr2.12026","title":"Utilizing resources of neuropsychopharmacology to address the opioid overdose crisis","year":2018,"lang":"en","type":"review","venue":"Neuropsychopharmacology Reports","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Providence Health Care; Vancouver Coastal Health Research Institute; St. Paul's Foundation","keywords":"Neuropsychopharmacology; Opioid; Medicine; Heroin; Opioid overdose; Psychiatry; Intensive care medicine; Drug; (+)-Naloxone","score_opus":0.044075735809668254,"score_gpt":0.39415142066551934,"score_spread":0.35007568485585105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886643569","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056964996,0.9963301,0.000091072965,0.0019659111,0.0005793832,0.000004362298,0.00000920616,0.0000056416166,0.0009572893],"genre_scores_gemma":[0.0007281268,0.9973603,0.0001867808,0.00083034794,0.0005428017,0.0000054917355,0.000013863906,0.0000014363519,0.00033090377],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995264,0.00016283605,0.00007676749,0.00004626823,0.00015441845,0.000033343364],"domain_scores_gemma":[0.9985171,0.0008216777,0.00017631115,0.00004825446,0.00034273075,0.00009395651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012634613,0.00059681124,0.00091358944,0.0028532245,0.0004679655,0.0015560241,0.0009843253,0.0017860314,0.004495468],"category_scores_gemma":[0.002814889,0.00021019512,0.0005085277,0.0021093234,0.00087215065,0.0022832854,0.0011322497,0.0023973626,0.00127141],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004152895,0.000054732238,0.0003352644,0.040872276,0.00015802038,0.0005009544,0.00033874554,0.00017997426,0.00079784537,0.008904072,0.08042016,0.8673963],"study_design_scores_gemma":[0.000011458742,0.000028802328,0.00057351415,0.012904026,0.00009084615,0.001308466,0.00023585011,0.00003725106,0.00015039246,0.0027722875,0.981873,0.000014103031],"about_ca_topic_score_codex":0.0014419889,"about_ca_topic_score_gemma":0.0033142872,"teacher_disagreement_score":0.004495468,"about_ca_system_score_codex":0.00075991964,"about_ca_system_score_gemma":0.0031760687,"threshold_uncertainty_score":0.015038848},"labels":[],"label_agreement":null},{"id":"W2944021932","doi":"10.1002/npr2.12058","title":"Alteration in AMPA receptor subunit expression and receptor binding among patients with addictive disorders: A systematic review of human postmortem studies","year":2019,"lang":"en","type":"review","venue":"Neuropsychopharmacology Reports","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Japan Agency for Medical Research and Development","keywords":"AMPA receptor; Protein subunit; Addiction; Receptor; Neuroscience; Biology; Postmortem studies; Medicine; Cell biology; Genetics; Glutamate receptor; Gene","score_opus":0.04878717219190591,"score_gpt":0.37217327824033025,"score_spread":0.3233861060484243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944021932","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025586833,0.99618524,0.00010851959,0.00010756321,0.000055167086,0.00012728953,0.0006500594,0.000004665867,0.00020275364],"genre_scores_gemma":[0.01993572,0.9783245,0.0004929056,0.00028932217,0.000060291084,0.00026628224,0.0005266966,0.000005204199,0.00009914294],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9958187,0.0007696421,0.0023881064,0.0004155865,0.00049362285,0.00011437723],"domain_scores_gemma":[0.9781607,0.0150312735,0.0044236938,0.0003384479,0.0018651019,0.00018078582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004203908,0.0011584433,0.0052780057,0.015807794,0.00063602085,0.0016381908,0.0015069275,0.0014183169,0.003551554],"category_scores_gemma":[0.019673014,0.00079410884,0.0040509026,0.016122999,0.0008136809,0.0018021865,0.001241338,0.00057536387,0.00029802608],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020359065,0.000014898483,0.0024763313,0.9566459,0.004349431,0.00039911247,0.0003249422,0.00004920184,0.00038049545,0.000114012684,0.0011687113,0.03387338],"study_design_scores_gemma":[0.00015176205,0.00026770702,0.016396662,0.8872438,0.067490906,0.0026017511,0.00074596895,0.000061753555,0.00043494225,0.00025633,0.024292475,0.000055988712],"about_ca_topic_score_codex":0.004477536,"about_ca_topic_score_gemma":0.013173853,"teacher_disagreement_score":0.015807794,"about_ca_system_score_codex":0.0017296366,"about_ca_system_score_gemma":0.0048524663,"threshold_uncertainty_score":0.022232592},"labels":[],"label_agreement":null},{"id":"W3011244690","doi":"10.1002/npr2.12103","title":"Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia","year":2020,"lang":"en","type":"article","venue":"Neuropsychopharmacology Reports","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; Douglas Mental Health University Institute; Centre for Addiction and Mental Health","funders":"","keywords":"Positive and Negative Syndrome Scale; Asenapine; Schizophrenia (object-oriented programming); Logistic regression; Psychiatry; Placebo; Psychology; Randomized controlled trial; Medicine; Internal medicine; Clinical psychology; Antipsychotic; Psychosis","score_opus":0.013269796495694751,"score_gpt":0.29335912919866525,"score_spread":0.2800893327029705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011244690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99916947,0.00020555577,0.0001684675,0.00005263013,0.000005338066,0.000008248769,0.00021995492,0.0000069729476,0.00016339739],"genre_scores_gemma":[0.99943644,0.000057027242,0.0001232765,0.000012333641,0.0000061980554,0.000006159688,0.0003016908,0.0000017018793,0.000055193796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999164,0.00040032124,0.000113605565,0.00012790789,0.00013407164,0.00006007193],"domain_scores_gemma":[0.9939804,0.0024880997,0.0024381822,0.00028862062,0.0003462166,0.00045841586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018701286,0.00051293854,0.00076272513,0.0005463981,0.00023545619,0.0005201636,0.0003081447,0.0004856634,0.0011187424],"category_scores_gemma":[0.0051699867,0.00026862905,0.001110276,0.0005473634,0.00020470921,0.0005084533,0.00044373737,0.001101801,0.0001753101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014824667,0.00008391439,0.9942168,0.000021669975,0.00018418743,0.000037882237,0.000036251084,0.00045145312,0.00043098832,0.000008406205,0.00006100054,0.0029848863],"study_design_scores_gemma":[0.000035946014,0.00044260273,0.9957391,0.0000101361475,0.00009175486,0.00007787342,0.00005792069,0.0032679818,0.00016663613,0.00004532753,0.00005480888,0.000009794113],"about_ca_topic_score_codex":0.001594366,"about_ca_topic_score_gemma":0.0027419836,"teacher_disagreement_score":0.0018701286,"about_ca_system_score_codex":0.0002530058,"about_ca_system_score_gemma":0.00034958488,"threshold_uncertainty_score":0.009890258},"labels":[],"label_agreement":null},{"id":"W4212978001","doi":"10.1002/npr2.12240","title":"Aripiprazole LAI two‐injection start in a 16 year‐old adolescent with schizophrenia","year":2022,"lang":"en","type":"article","venue":"Neuropsychopharmacology Reports","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aripiprazole; Akathisia; Schizophrenia (object-oriented programming); Positive and Negative Syndrome Scale; Clinical Global Impression; Medicine; Psychiatry; Psychology; Internal medicine; Antipsychotic; Pediatrics; Psychosis; Placebo","score_opus":0.016619186459387772,"score_gpt":0.30602719202096024,"score_spread":0.2894080055615725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212978001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845917,0.0023742027,0.0005370656,0.0046472135,0.00024912972,0.00014579929,0.00016715223,0.000040134135,0.0033802278],"genre_scores_gemma":[0.99349654,0.0018863517,0.00057291216,0.0022714795,0.00015473408,0.000026913918,0.00008980303,0.000014064809,0.00148708],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998023,0.000020701144,0.000028503922,0.0000444836,0.000041569027,0.00006248528],"domain_scores_gemma":[0.9994808,0.000039924453,0.00010581999,0.000008809973,0.000030582018,0.0003340507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025411666,0.0008025706,0.00074971473,0.0007498401,0.0020922408,0.00050944026,0.00041525086,0.0019570868,0.001474878],"category_scores_gemma":[0.0007723336,0.00048119514,0.0007703155,0.00042220915,0.0007047226,0.0010564841,0.0007241136,0.0029036507,0.00044350032],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001739108,0.00045159322,0.037787493,0.000098474986,0.0000265786,0.9524621,0.0010296977,0.00013684538,0.0021137763,0.00028574606,0.00080326473,0.004630557],"study_design_scores_gemma":[0.00008003907,0.0010339937,0.05331289,0.000120169265,0.00004573777,0.94101644,0.0011573853,0.00059968134,0.0004526447,0.00023845237,0.0019026778,0.000039926763],"about_ca_topic_score_codex":0.009872427,"about_ca_topic_score_gemma":0.020429894,"teacher_disagreement_score":0.009872427,"about_ca_system_score_codex":0.0014631101,"about_ca_system_score_gemma":0.0013965432,"threshold_uncertainty_score":0.019629955},"labels":[],"label_agreement":null},{"id":"W4308178908","doi":"10.1002/npr2.12299","title":"Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data","year":2022,"lang":"en","type":"article","venue":"Neuropsychopharmacology Reports","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"National Institutes of Health","keywords":"Logistic regression; Sertraline; Pharmacotherapy; Fluvoxamine; Psychiatry; Clinical Global Impression; Post-hoc analysis; Fluoxetine; Anxiety; Medicine; Odds ratio; Psychology; Internal medicine; Clinical psychology; Placebo; Antidepressant","score_opus":0.025063572708936662,"score_gpt":0.3515067924885094,"score_spread":0.32644321977957275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308178908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98958963,0.006190528,0.0012113804,0.00014198186,0.00009532411,0.0008580844,0.001221335,0.000042717533,0.00064894627],"genre_scores_gemma":[0.9955793,0.00065698824,0.001021658,0.000065359454,0.00007469353,0.0010784861,0.001122851,0.000020689846,0.00038004134],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97532576,0.019656599,0.0016044274,0.0014336678,0.0012397349,0.0007398953],"domain_scores_gemma":[0.9615696,0.02982024,0.0047361604,0.0019333882,0.0010894346,0.0008512207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020127518,0.0013016082,0.0050356193,0.0012183406,0.00041569723,0.0014541453,0.0008843897,0.0011053786,0.0029351164],"category_scores_gemma":[0.018913232,0.00042554532,0.0073311087,0.0011797082,0.000782092,0.0011778078,0.0010161725,0.001478882,0.00021382066],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6407215,0.001947999,0.22936228,0.00279701,0.098186225,0.0004077797,0.00019420762,0.0032211782,0.0032752277,0.000145224,0.0009786214,0.01876277],"study_design_scores_gemma":[0.11101226,0.14683191,0.5835194,0.0004235114,0.13062742,0.00090574136,0.00035467534,0.017837152,0.003885922,0.000527118,0.0038866966,0.00018813755],"about_ca_topic_score_codex":0.00042175315,"about_ca_topic_score_gemma":0.0008855167,"teacher_disagreement_score":0.020127518,"about_ca_system_score_codex":0.00059548026,"about_ca_system_score_gemma":0.0010648364,"threshold_uncertainty_score":0.10644579},"labels":[],"label_agreement":null},{"id":"W4382795089","doi":"10.1002/npr2.12363","title":"Highly endorsed screening and assessment scales for alcohol problems: A systematic review","year":2023,"lang":"en","type":"review","venue":"Neuropsychopharmacology Reports","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"PsycINFO; Psychometrics; Systematic review; MEDLINE; Alcohol Use Disorders Identification Test; Psychology; Rating scale; Audit; Clinical psychology; Scale (ratio); Alcohol use disorder; Psychiatry; Alcohol; Medicine; Poison control; Injury prevention; Environmental health; Developmental psychology","score_opus":0.11773620050180231,"score_gpt":0.44123519293347774,"score_spread":0.32349899243167546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382795089","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014941518,0.9966724,0.00022650982,0.00022843924,0.00007485674,0.0006092724,0.00042227423,0.000010470621,0.00026157213],"genre_scores_gemma":[0.025222281,0.9705227,0.0018048859,0.00039697136,0.000079483856,0.0013460846,0.0005076181,0.000006654441,0.00011333115],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98659,0.0044953153,0.0047189235,0.0007837031,0.0031205488,0.00029146846],"domain_scores_gemma":[0.94441825,0.03787425,0.011039503,0.0008014603,0.0054079457,0.00045866382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015682017,0.0013867526,0.006593703,0.01373984,0.00081221334,0.0021093355,0.0019411839,0.0015937284,0.0035158459],"category_scores_gemma":[0.06197367,0.00087839516,0.006829561,0.012086565,0.0011177916,0.0024083904,0.0016274452,0.0010370841,0.00032915364],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020945996,0.00003266945,0.0024388495,0.916852,0.008015852,0.00007259095,0.00021311772,0.00009068955,0.00010292695,0.0001658294,0.0018462869,0.06995981],"study_design_scores_gemma":[0.00037986276,0.00021353897,0.015021564,0.9123283,0.058638975,0.0004424972,0.00037521942,0.00014269409,0.00015190706,0.00032662007,0.01192355,0.000055207413],"about_ca_topic_score_codex":0.008343689,"about_ca_topic_score_gemma":0.028354507,"teacher_disagreement_score":0.015682017,"about_ca_system_score_codex":0.0038534685,"about_ca_system_score_gemma":0.012112847,"threshold_uncertainty_score":0.08293539},"labels":[],"label_agreement":null},{"id":"W4384663944","doi":"10.1002/npr2.12350","title":"At‐risk internet addiction and related factors among senior high school teachers in Japan based on a Nationwide survey","year":2023,"lang":"en","type":"article","venue":"Neuropsychopharmacology Reports","topic":"Impact of Technology on Adolescents","field":"Social Sciences","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Japan Society for the Promotion of Science","keywords":"Addiction; The Internet; Psychology; Entertainment; Cross-sectional study; Test (biology); Demography; Medicine; Family medicine; Environmental health; Psychiatry; Sociology; Political science; Computer science; World Wide Web","score_opus":0.014686200708623342,"score_gpt":0.3112139775117231,"score_spread":0.2965277768030997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384663944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989675,0.00013675976,0.0000359183,0.00005218178,0.00000462613,0.000014734599,0.00045420922,0.0000030376711,0.0003309948],"genre_scores_gemma":[0.99871933,0.00018794311,0.000048487433,0.000060253133,0.0000075302305,0.00002027081,0.0007373882,0.0000016592059,0.00021712913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996507,0.000041370695,0.00006610778,0.000066839144,0.00009515382,0.00007981013],"domain_scores_gemma":[0.9990189,0.00005071382,0.00038178952,0.00003853478,0.00020014042,0.00030977846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047526747,0.00022676839,0.0003541339,0.0011158495,0.00048422554,0.0005298465,0.00030365007,0.00030367757,0.0010913413],"category_scores_gemma":[0.0009264974,0.00040130122,0.00041615,0.0011538287,0.00019648834,0.0004921467,0.00054455805,0.0004870217,0.00021256425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006519147,0.000027030032,0.99915767,0.000012955022,0.000011675748,0.000028472292,0.00013516587,0.000006056865,0.00005888843,0.000003973822,0.00012231921,0.00042933229],"study_design_scores_gemma":[0.0000012102156,0.000014319904,0.99933654,0.000007762968,0.000008358137,0.0000395389,0.0004596204,0.00003012468,0.000007696815,0.0000024982658,0.000090830814,0.0000015416576],"about_ca_topic_score_codex":0.030702278,"about_ca_topic_score_gemma":0.041333444,"teacher_disagreement_score":0.030702278,"about_ca_system_score_codex":0.0004426261,"about_ca_system_score_gemma":0.0005272494,"threshold_uncertainty_score":0.061047196},"labels":[],"label_agreement":null},{"id":"W4387357477","doi":"10.1002/npr2.12382","title":"Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review","year":2023,"lang":"en","type":"review","venue":"Neuropsychopharmacology Reports","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Ottawa Mental Health Centre; University of Ottawa","funders":"","keywords":"PsycINFO; Neurocognitive; Schizophrenia (object-oriented programming); Cognition; Psychology; Clinical psychology; MEDLINE; Psychiatry; Quality of life (healthcare); CINAHL; Medicine; Psychotherapist; Psychological intervention","score_opus":0.07327235464547761,"score_gpt":0.44326760256340636,"score_spread":0.36999524791792876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387357477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016278055,0.999466,0.000023313469,0.00006123974,0.000040822015,0.00001798631,0.000030725747,0.000002169479,0.00019498993],"genre_scores_gemma":[0.0009896265,0.99872476,0.00008097086,0.00007856164,0.000033934197,0.000020157893,0.000023831899,5.085816e-7,0.00004764428],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993765,0.0001421182,0.00024585883,0.00006488916,0.0001385212,0.00003209411],"domain_scores_gemma":[0.99824893,0.0011758705,0.00036620296,0.000021920814,0.0001531113,0.000033954373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011485957,0.000928441,0.0021968505,0.004569737,0.00035521318,0.0012495333,0.0011329364,0.0009960353,0.0032667862],"category_scores_gemma":[0.0035526832,0.00034339738,0.0016667974,0.0055215824,0.00037467948,0.0010145482,0.00063526025,0.0006590783,0.0003977997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001390469,0.000037543643,0.0002979574,0.7231416,0.0010665555,0.0002562901,0.00022307444,0.00015638233,0.00039887952,0.0006976987,0.0072148726,0.26637012],"study_design_scores_gemma":[0.000148518,0.00036578218,0.005124177,0.7259628,0.0139878,0.0031411874,0.00052568177,0.0001659694,0.00048512,0.0009465436,0.24908683,0.00005952513],"about_ca_topic_score_codex":0.0027654883,"about_ca_topic_score_gemma":0.005426447,"teacher_disagreement_score":0.004569737,"about_ca_system_score_codex":0.00096650515,"about_ca_system_score_gemma":0.0030879974,"threshold_uncertainty_score":0.010928452},"labels":[],"label_agreement":null},{"id":"W4392385372","doi":"10.1002/npr2.12421","title":"Research hotspots and frontiers of alcohol and epilepsy: A bibliometric analysis","year":2024,"lang":"en","type":"article","venue":"Neuropsychopharmacology Reports","topic":"Alcoholism and Thiamine Deficiency","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epilepsy; Epileptogenesis; Web of science; Alcohol dependence; Field (mathematics); Psychology; Medicine; Psychiatry; Alcohol; Meta-analysis; Pathology","score_opus":0.04438360297153727,"score_gpt":0.4081835875724664,"score_spread":0.36379998460092916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392385372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8066762,0.10002511,0.0044766963,0.0036345387,0.00017973826,0.0014510825,0.0648843,0.0005102528,0.018162208],"genre_scores_gemma":[0.9356658,0.038137764,0.0079039605,0.000118300195,0.00018990836,0.000742177,0.016153144,0.000060530834,0.001028383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99285746,0.0014100256,0.0018655201,0.00072100316,0.002756241,0.00038980125],"domain_scores_gemma":[0.9654069,0.021672571,0.005825394,0.00083202583,0.005510866,0.00075226947],"candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.0058148275,0.0007384616,0.002129369,0.18613108,0.0014878821,0.0042270347,0.00075759,0.00056845316,0.0041836104],"category_scores_gemma":[0.028561452,0.00032491345,0.002340513,0.18879978,0.0008898413,0.0030857862,0.002771759,0.0003759081,0.0005395786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058489316,0.00015331444,0.72019297,0.048199438,0.0050646993,0.001241998,0.005447703,0.0021072647,0.0034231937,0.0050108186,0.011172893,0.19740088],"study_design_scores_gemma":[0.000096971766,0.0002890118,0.9132899,0.007790946,0.0063436935,0.0022858584,0.013147779,0.005880965,0.0016844692,0.005056201,0.043978214,0.0001558751],"about_ca_topic_score_codex":0.006691983,"about_ca_topic_score_gemma":0.008129194,"teacher_disagreement_score":0.81386894,"about_ca_system_score_codex":0.0027006625,"about_ca_system_score_gemma":0.0057308553,"threshold_uncertainty_score":0.030752063},"labels":[],"label_agreement":null},{"id":"W4394694221","doi":"10.1002/npr2.12431","title":"Co‐administration of probiotic and vitamin D significantly improves cognitive function in schizophrenic patients: A double‐blinded randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"Neuropsychopharmacology Reports","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Montreal Cognitive Assessment; Placebo; Probiotic; Gastroenterology; Vitamin; Positive and Negative Syndrome Scale; Schizophrenia (object-oriented programming); Randomized controlled trial; Placebo-controlled study; Vitamin D and neurology; Physical therapy; Psychiatry; Cognitive impairment; Disease; Double blind; Psychosis","score_opus":0.00969259604551221,"score_gpt":0.30652710628724256,"score_spread":0.29683451024173035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394694221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.914967,0.06032959,0.0015361533,0.001523757,0.0033103568,0.014394606,0.0017323977,0.00024813475,0.0019579232],"genre_scores_gemma":[0.94770384,0.023559391,0.0032518292,0.0021254334,0.0014567615,0.01730509,0.00085939554,0.00002573487,0.0037124981],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99913955,0.00037528411,0.000130595,0.00017402448,0.00009240607,0.00008811909],"domain_scores_gemma":[0.9991258,0.00021075919,0.00023189747,0.0000614333,0.00010871854,0.00026143022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016544415,0.0013569515,0.0059551243,0.00062605663,0.0008150789,0.0011429993,0.0009789175,0.002761014,0.006520284],"category_scores_gemma":[0.001985869,0.0007959544,0.0022410175,0.0006341626,0.0010405157,0.00089199113,0.0005986129,0.0023174623,0.0006753094],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98019665,0.005789506,0.00022801553,0.0029540106,0.0023121762,0.000022795977,0.000025449577,0.000050028404,0.0010559764,0.000031576663,0.0002816223,0.007052298],"study_design_scores_gemma":[0.9579701,0.038590603,0.0010030835,0.0001792494,0.0014335433,0.000013207062,0.00002008964,0.00013008884,0.00019618661,0.000051831506,0.0003998178,0.000012128417],"about_ca_topic_score_codex":0.0013663684,"about_ca_topic_score_gemma":0.0026077367,"teacher_disagreement_score":0.006520284,"about_ca_system_score_codex":0.0005793441,"about_ca_system_score_gemma":0.0012370357,"threshold_uncertainty_score":0.021812499},"labels":[],"label_agreement":null},{"id":"W4398218879","doi":"10.1002/npr2.12449","title":"Cluster analysis of patients with alcohol use disorder featuring alexithymia, depression, and diverse drinking behavior","year":2024,"lang":"en","type":"article","venue":"Neuropsychopharmacology Reports","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Japan Society for the Promotion of Science","keywords":"Alexithymia; Psychology; Clinical psychology; Pathological; Mood; Depression (economics); Alcohol use disorder; Cluster (spacecraft); Mood disorders; Psychiatry; Medicine; Alcohol; Anxiety; Internal medicine","score_opus":0.013194531033814934,"score_gpt":0.2967593510463821,"score_spread":0.28356482001256716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398218879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994842,0.00003465319,0.0002367601,0.000010548719,0.0000022402874,0.00001838261,0.000051801537,0.0000048525935,0.00015655844],"genre_scores_gemma":[0.9995154,0.000013955348,0.00023437201,0.0000042986626,0.00000267818,0.000009861964,0.00014970938,0.0000012623481,0.00006850287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973744,0.000057149617,0.000037117385,0.00007777509,0.000041066476,0.000049482325],"domain_scores_gemma":[0.99968946,0.000043190073,0.000087164604,0.00003546916,0.000062151616,0.00008258806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002860566,0.00023509994,0.0003918529,0.0011334955,0.00056718243,0.00034099046,0.00015801814,0.0001800819,0.0013169189],"category_scores_gemma":[0.0010264971,0.00011688534,0.0003861265,0.0005328727,0.00021262282,0.00017474816,0.0005592489,0.00017147521,0.000184973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053798285,0.00005942568,0.98915917,0.000023191362,0.00007667568,0.0002541307,0.0004120885,0.0001692007,0.0035075522,0.00004879481,0.00014769942,0.0056038876],"study_design_scores_gemma":[0.000022012524,0.00023321086,0.9965042,0.0000055292076,0.000039796138,0.0007731199,0.0005870608,0.0010662184,0.00047083478,0.000118744305,0.00017173454,0.000007463922],"about_ca_topic_score_codex":0.0028568709,"about_ca_topic_score_gemma":0.003404089,"teacher_disagreement_score":0.0028568709,"about_ca_system_score_codex":0.0002889013,"about_ca_system_score_gemma":0.00036513113,"threshold_uncertainty_score":0.005680442},"labels":[],"label_agreement":null},{"id":"W4405088732","doi":"10.1002/npr2.12509","title":"Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms","year":2024,"lang":"en","type":"article","venue":"Neuropsychopharmacology Reports","topic":"Sleep and related disorders","field":"Psychology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"Eisai Canada","keywords":"Anxiety; Placebo; Insomnia; Population; Depression (economics); Medicine; Randomized controlled trial; Psychiatry; Internal medicine; Sleep disorder; Sleep onset; Psychology; Physical therapy","score_opus":0.008847853756365388,"score_gpt":0.3170689237414162,"score_spread":0.30822106998505083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405088732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99305785,0.005204915,0.00016681099,0.00015774695,0.00004364866,0.00031552475,0.00026049628,0.00003568406,0.000757263],"genre_scores_gemma":[0.99626166,0.0016359766,0.00036854364,0.00038400711,0.00013227352,0.00027498428,0.00032000197,0.000004398538,0.00061799696],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996314,0.00020350589,0.000042218682,0.000045628734,0.000038222057,0.000039024904],"domain_scores_gemma":[0.9994048,0.00015302887,0.00024970953,0.000035083503,0.000045488236,0.00011193623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011584603,0.00037291026,0.0008966783,0.00023430465,0.0002965367,0.00030706695,0.0002721842,0.0006053708,0.0031007212],"category_scores_gemma":[0.0011000931,0.00020397118,0.00078985136,0.0001969,0.00028206446,0.00027528306,0.00019376056,0.0006500441,0.0004235271],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74265623,0.01256841,0.029633725,0.00197857,0.00171687,0.00022042419,0.00024077941,0.0003617117,0.048750237,0.00006227948,0.0011566504,0.16065405],"study_design_scores_gemma":[0.18577985,0.56667155,0.23717217,0.0001918688,0.0016280203,0.00035119473,0.00016840642,0.0006512742,0.004734475,0.00009824877,0.002520712,0.000032324748],"about_ca_topic_score_codex":0.00055230386,"about_ca_topic_score_gemma":0.0019740334,"teacher_disagreement_score":0.0031007212,"about_ca_system_score_codex":0.00031035533,"about_ca_system_score_gemma":0.0004160925,"threshold_uncertainty_score":0.010372937},"labels":[],"label_agreement":null},{"id":"W4405383229","doi":"10.1002/npr2.12500","title":"Effects of short‐term exposure to moderate amounts of alcohol on brain volume","year":2024,"lang":"en","type":"article","venue":"Neuropsychopharmacology Reports","topic":"Alcoholism and Thiamine Deficiency","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Alcohol; Anesthesia; Ventricle; Medicine; Cerebrospinal fluid; Brain size; Ethanol; Cardiology; Internal medicine; Chemistry; Magnetic resonance imaging; Biochemistry; Radiology","score_opus":0.015362042629697016,"score_gpt":0.32929055268814755,"score_spread":0.3139285100584505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405383229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990006,0.0006266621,0.00015677053,0.000018269007,0.0000081276685,0.000008485358,0.00004360948,0.000007568888,0.0001299237],"genre_scores_gemma":[0.9986358,0.0004968163,0.00023515624,0.000026092986,0.000010600146,0.000022080849,0.00010131746,0.0000034925647,0.00046872316],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999392,0.000011975642,0.000004756781,0.000016603177,0.000012765902,0.000014633778],"domain_scores_gemma":[0.9998066,0.000039887753,0.000060318784,0.000022005013,0.000018722616,0.00005249841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001047846,0.0002364688,0.0001920789,0.00008387774,0.00010188989,0.00016632702,0.00011060222,0.00021078977,0.0013030166],"category_scores_gemma":[0.00027079706,0.000101796075,0.00014872584,0.000052441064,0.00026278643,0.0001344495,0.00019750716,0.00027890017,0.00012286809],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023526782,0.0009865154,0.017283477,0.00016887329,0.00015140418,0.00026405987,0.00012273848,0.00015314476,0.93635094,0.000042016767,0.00010494374,0.020845095],"study_design_scores_gemma":[0.00029754924,0.053306118,0.59650147,0.000030428357,0.00027703313,0.00066517724,0.00022374582,0.0010274523,0.3459562,0.00014456887,0.0015457519,0.000024464496],"about_ca_topic_score_codex":0.0010049347,"about_ca_topic_score_gemma":0.0017197374,"teacher_disagreement_score":0.0013030166,"about_ca_system_score_codex":0.00014465587,"about_ca_system_score_gemma":0.00014173806,"threshold_uncertainty_score":0.004359007},"labels":[],"label_agreement":null},{"id":"W4406223623","doi":"10.1002/npr2.12519","title":"Residual Fatigue in Unipolar and Bipolar Depression: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Neuropsychopharmacology Reports","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Gdański Uniwersytet Medyczny","keywords":"Modafinil; Depression (economics); Medicine; Randomized controlled trial; Bipolar disorder; Major depressive disorder; Systematic review; Psychological intervention; Psychiatry; Residual; Meta-analysis; Internal medicine; MEDLINE; Physical therapy; Clinical psychology; Mood","score_opus":0.0315704153038312,"score_gpt":0.3864708032162476,"score_spread":0.3549003879124164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406223623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008623277,0.99820936,0.00007648581,0.00015068182,0.000063924876,0.00024391014,0.00021269574,0.000005145045,0.00017534911],"genre_scores_gemma":[0.017648675,0.9803058,0.00050491537,0.0005124,0.00007960841,0.0006133084,0.0002099826,0.0000037233103,0.00012160397],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960174,0.0014050201,0.0013358119,0.000331875,0.00074518606,0.0001647103],"domain_scores_gemma":[0.98679775,0.008908298,0.0029399667,0.00017051699,0.000985944,0.0001975643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005145815,0.0012591592,0.0073766652,0.006436425,0.00052961573,0.0018606652,0.0013478647,0.0017004042,0.004383421],"category_scores_gemma":[0.020710278,0.0009447608,0.006657614,0.0061916662,0.000612884,0.0015492876,0.0011711394,0.0009572209,0.00026889401],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015047737,0.000011722996,0.00058178476,0.9669814,0.0072067305,0.00008138621,0.00011997399,0.00006556664,0.00009499399,0.00011943882,0.0011806162,0.023405919],"study_design_scores_gemma":[0.000371022,0.000262949,0.00597791,0.8994179,0.07778564,0.0005317355,0.00024258584,0.00010403481,0.000112074486,0.00027286238,0.014884474,0.000036885704],"about_ca_topic_score_codex":0.008114486,"about_ca_topic_score_gemma":0.02709211,"teacher_disagreement_score":0.008114486,"about_ca_system_score_codex":0.0027659934,"about_ca_system_score_gemma":0.0086969305,"threshold_uncertainty_score":0.02721399},"labels":[],"label_agreement":null},{"id":"W4408070484","doi":"10.1002/npr2.70008","title":"Efficacy of Pharmacological Interventions in Milder Depression: A Systematic Review and Meta‐Analysis","year":2025,"lang":"en","type":"review","venue":"Neuropsychopharmacology Reports","topic":"Medicinal Plants and Bioactive Compounds","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Japan Society for the Promotion of Science; Canadian Institutes of Health Research; H. Lundbeck A/S; Mitsubishi Tanabe Pharma Corporation; Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; Teijin Pharma; Meiji Seika Pharma; Shionogi; SENSHIN Medical Research Foundation; Eli Lilly and Company; Ono Pharmaceutical; Eisai; EA Pharma Co., Ltd.; Boehringer Ingelheim Japan; Mylan; Kowa Company; Daiichi Sankyo Europe; Japanese Society of Clinical Neuropsychopharmacology; Dainippon Sumitomo Pharma; Pfizer; Japan Research Foundation for Clinical Pharmacology; Takeda Pharmaceutical Company; Otsuka Pharmaceutical; Japan Agency for Medical Research and Development; Ministry of Health, Labour and Welfare; Brain and Behavior Research Foundation","keywords":"Meta-analysis; Depression (economics); Psychological intervention; Psychology; Systematic review; Medicine; Psychotherapist; MEDLINE; Psychiatry; Internal medicine; Political science","score_opus":0.0667600139594555,"score_gpt":0.4244481175867719,"score_spread":0.3576881036273164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408070484","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003053409,0.9955617,0.0003091469,0.00012408114,0.000090476504,0.00039987202,0.00028115924,0.0000178902,0.00016233778],"genre_scores_gemma":[0.09709595,0.89756256,0.0021057143,0.0007482901,0.00020179522,0.0015039314,0.0005435019,0.000017536411,0.00022077242],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9923228,0.00353434,0.0022375316,0.00071886595,0.00094228983,0.00024406816],"domain_scores_gemma":[0.9851435,0.010725945,0.0026357027,0.0003796393,0.00091851945,0.00019673546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011836651,0.0028383986,0.02176216,0.006686134,0.0006231023,0.002826845,0.0021378675,0.0023151569,0.0042987103],"category_scores_gemma":[0.023906259,0.0012885162,0.0345031,0.0063429684,0.0007880451,0.0016258191,0.0014880112,0.0017881673,0.00027319344],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023922217,0.00006240691,0.0014618235,0.6092041,0.36879754,0.00009519676,0.0000770826,0.0003913555,0.00020008166,0.00012858408,0.0004976056,0.016691959],"study_design_scores_gemma":[0.0013842947,0.0004028466,0.0026620317,0.05227149,0.94096786,0.0000878597,0.00004734764,0.00017402542,0.00012563328,0.00017302523,0.0016807398,0.000022819788],"about_ca_topic_score_codex":0.0053363396,"about_ca_topic_score_gemma":0.012440452,"teacher_disagreement_score":0.02176216,"about_ca_system_score_codex":0.0028444445,"about_ca_system_score_gemma":0.0038481168,"threshold_uncertainty_score":0.06259894},"labels":[],"label_agreement":null},{"id":"W4412410957","doi":"10.1002/npr2.70039","title":"Primary Progressive Multiple Sclerosis: New Therapeutic Approaches","year":2025,"lang":"en","type":"review","venue":"Neuropsychopharmacology Reports","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brandon Regional Health Authority; Winnipeg Regional Health Authority","funders":"","keywords":"Medicine; Multiple sclerosis; Remyelination; Fingolimod; Neuroprotection; Alemtuzumab; Ocrelizumab; Neuroinflammation; Glatiramer acetate; Oncology; Internal medicine; Bioinformatics; Immunology; Central nervous system; Transplantation; Myelin; Lymphoma; Inflammation; Rituximab","score_opus":0.23081570576838248,"score_gpt":0.40327534192859177,"score_spread":0.1724596361602093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412410957","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035998248,0.99928135,0.0000337064,0.0001968821,0.00008896618,0.00000280683,0.00000499845,0.0000033894598,0.0003519194],"genre_scores_gemma":[0.00037357284,0.99900335,0.00009183714,0.00017810057,0.00012257014,0.000005165723,0.000011006187,7.8677596e-7,0.00021371334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971634,0.0000625925,0.00004656127,0.000045724355,0.000104832616,0.000023856745],"domain_scores_gemma":[0.99961746,0.00019328124,0.000052469462,0.0000139757385,0.00009132668,0.000031556658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008189845,0.0009633178,0.0016607778,0.0032748515,0.00028737553,0.0011272416,0.000897489,0.0011995478,0.005372474],"category_scores_gemma":[0.00082547544,0.00026586553,0.00073921354,0.0022702212,0.00061697036,0.001575986,0.0007487108,0.0019897078,0.0018616519],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010117812,0.00008308308,0.00009625277,0.031209767,0.00012499372,0.00021254283,0.000070734284,0.00023518181,0.00074247975,0.003336731,0.023096949,0.94069016],"study_design_scores_gemma":[0.0000657459,0.0001356893,0.0006563709,0.014543293,0.0002709949,0.0017355843,0.00010600833,0.000078474484,0.00026796854,0.002794085,0.9793255,0.000020401658],"about_ca_topic_score_codex":0.0012036791,"about_ca_topic_score_gemma":0.0022369982,"teacher_disagreement_score":0.005372474,"about_ca_system_score_codex":0.0007738567,"about_ca_system_score_gemma":0.001223122,"threshold_uncertainty_score":0.017972708},"labels":[],"label_agreement":null},{"id":"W4415474868","doi":"10.1002/npr2.70066","title":"The Effect of N‐Acetylcysteine ( <scp>NAC</scp> ) on Neurometabolites and Cognitive Function in Adults With Alcohol Use Disorder: A Preliminary Randomized Controlled Trial","year":2025,"lang":"en","type":"article","venue":"Neuropsychopharmacology Reports","topic":"Alcoholism and Thiamine Deficiency","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Health and Medical Research Council; Medical Research Council; University of Sydney","keywords":"Randomized controlled trial; Cognition; Alcohol; Function (biology); Alcohol consumption","score_opus":0.005491139560733854,"score_gpt":0.2771678136539189,"score_spread":0.2716766740931851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415474868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807046,0.008834551,0.0005051357,0.00081012386,0.00055612426,0.0060134926,0.0009580171,0.00013000576,0.0014879032],"genre_scores_gemma":[0.986858,0.0038242799,0.001523629,0.0006788214,0.00040597495,0.0044371476,0.000558058,0.000011353179,0.0017027349],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993092,0.0003465712,0.00009029735,0.00011619215,0.00005810004,0.00007961557],"domain_scores_gemma":[0.99871886,0.0003733929,0.00025460136,0.00007927156,0.00016552556,0.0004084586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016144227,0.0011335253,0.0024463255,0.00044692183,0.0005662169,0.00091349846,0.000746736,0.0016690475,0.0045480025],"category_scores_gemma":[0.0019786968,0.0005123021,0.0020208624,0.00049169915,0.00087493146,0.0008009185,0.00034190042,0.0017455675,0.00054688315],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9816019,0.004238195,0.00054144795,0.0007320524,0.0013442225,0.000035902154,0.00003477484,0.00008543216,0.0019568873,0.000039020106,0.00032626296,0.009063945],"study_design_scores_gemma":[0.9231152,0.07241451,0.0024435294,0.00005059396,0.00090377964,0.000021375954,0.00002574545,0.00020961175,0.00032915105,0.00005759719,0.00041858474,0.000010346085],"about_ca_topic_score_codex":0.0023678094,"about_ca_topic_score_gemma":0.006051051,"teacher_disagreement_score":0.0045480025,"about_ca_system_score_codex":0.0007259429,"about_ca_system_score_gemma":0.0014940398,"threshold_uncertainty_score":0.015214622},"labels":[],"label_agreement":null}]}